PRESS RELEASE published on 07/18/2024 at 19:00, 1 year 9 months ago DocVA Launches Cutting-Edge Virtual Medical Assistant Services, Revolutionizing Healthcare Operations DocVA launches comprehensive suite of remote healthcare support services to enhance patient care and streamline practice operations. Virtual assistants handle administrative and clinical tasks Virtual Assistant Patient Care Healthcare Support DocVA Remote Services
PRESS RELEASE published on 07/18/2024 at 18:45, 1 year 9 months ago Sustained hypergrowth in recurring business in H1 2024 WALLIX reports strong business performance for H1 2024 with 30.2% growth in MRR, 71.6% turnover from recurring business, and positive operating profit outlook Financial Performance Cybersecurity Operating Profit WALLIX Recurring Business
PRESS RELEASE published on 07/18/2024 at 18:45, 1 year 9 months ago Hyper croissance maintenue des revenus récurrents au 1er semestre 2024 WALLIX annonce une forte progression du revenu mensuel récurrent, une hausse de la part des revenus récurrents dans le CA et des objectifs financiers confirmés pour 2024 Croissance Revenus Récurrents Cybersécurité WALLIX IAM
PRESS RELEASE published on 07/18/2024 at 18:44, 1 year 9 months ago Informations privilégiées / Autres communiqués IntegraGen annonce un chiffre d'affaires de 4,5 M€ au premier semestre 2024, en hausse de 6%, avec une trésorerie de 2,8 M€. Perspectives de croissance et stratégie de réduction des coûts Chiffre D'affaires Croissance Trésorerie Certification CLIA IntegraGen
PRESS RELEASE published on 07/18/2024 at 18:40, 1 year 9 months ago Befesa extends the maturity of its debt to 2029 Befesa successfully extends debt maturity to 2029 with new financing terms maintaining credit ratings. Services focus on circular economy in steel & aluminium industries Debt Maturity Refinancing Circular Economy Befesa Credit Ratings
PRESS RELEASE published on 07/18/2024 at 18:30, 1 year 9 months ago Half-year results 2024 of SartoriusStedimBiotech Sartorius Stedim Biotech reports half-year results for 2024 with sales revenue of 1,373 million euros and a cautious outlook for the year ahead due to market volatility Volatility Sartorius Stedim Biotech Sales Revenue Outlook Half-year Results
PRESS RELEASE published on 07/18/2024 at 18:30, 1 year 9 months ago Résultats de Sartorius Stedim Biotech pour le premier semestre 2024 Résultats semestriels de Sartorius Stedim Biotech avec chiffre d’affaires en baisse organique de 3,8%, EBITDA à 387 millions d’euros et perspectives prudentes pour 2024 Chiffre D'affaires Résultats Semestriels EBITDA Sartorius Stedim Biotech Perspectives 2024
PRESS RELEASE published on 07/18/2024 at 18:28, 1 year 9 months ago Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive Sartorius AG reports moderately positive revenue development in Q2, cautious full-year outlook due to market volatility. Long-term prospects remain positive Market Volatility Sartorius AG Cautious Outlook Long-term Prospects Revenue Development
PRESS RELEASE published on 07/18/2024 at 18:22, 1 year 9 months ago EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024 Sartorius AG adjusts fiscal year 2024 guidance & reports H1 results amid challenging market. Sales revenue down, EBITDA & net profit decline Market Challenges Fiscal Year 2024 Sartorius AG Guidance Adjustment Sales Revenue Decline
PRESS RELEASE published on 07/18/2024 at 18:21, 1 year 9 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024 Sartorius Stedim Biotech adjusts fiscal year 2024 guidance with positive sales trend in H1 2024 amid volatile market. Company's key financials and outlook disclosed Fiscal Year 2024 Sartorius Stedim Biotech Outlook Sales Trend Key Financial Indicators
Published on 05/16/2026 at 01:15, 1 hour 32 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 hours 47 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 3 hours 37 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 3 hours 47 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 6 hours 37 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 8 hours 36 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 9 hours 13 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 11 hours 39 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 11 hours 47 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 16 hours 37 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 17 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 8 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES